Deconstructing the Drug Development Process: The New Face of Innovation
Top Cited Papers
- 3 February 2010
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 87 (3), 356-361
- https://doi.org/10.1038/clpt.2009.293
Abstract
Forged in the early 1960s, the paradigm for pharmaceutical innovation has remained virtually unchanged for nearly 50 years. During a period when most other research‐based industries have made frequen...Keywords
This publication has 6 references indexed in Scilit:
- Trends in Risks Associated With New Drug Development: Success Rates for Investigational DrugsClinical Pharmacology & Therapeutics, 2010
- Translational Medicine: An Engine of Change for Bringing New Technology to Community HealthScience Translational Medicine, 2009
- Assessing the Impact of Protocol Design Changes on Clinical Trial PerformanceClinical Journal of Sport Medicine, 2008
- The cost of biopharmaceutical R&D: is biotech different?Managerial and Decision Economics, 2007
- Returns on Research and Development for 1990s New Drug IntroductionsPharmacoEconomics, 2002
- Risks in new drug development: Approval success rates for investigational drugsClinical Pharmacology & Therapeutics, 2001